footer-logo.png

Watch the free recorded webinar: Harmonizing Disparate Quality Systems

Get answers to the biggest quality system questions medical device companies face when undergoing a merger, acquisition, or technology transfer.

45-minute presentation with 15-minute Q&A


fda-LinkedInAd-DisparateQualitySystems-Webinar-01.pngIn 2015 and 2016, there were over 150 major medical device company acquisitions and mergers, and that trend has only accelerated in 2017. These events often bring important questions regarding quality that can have far-reaching consequences if not addressed thoroughly by both department and company leadership.

We've compiled insights from experts with firsthand experience helping device manufacturers make informed decisions when integrating quality systems and performing the due diligence necessary to ensure compliance in both the short and long term.

You'll learn:

  • Factors to consider when deciding whether an incoming quality system should be retained or changed
  • A process to follow to ensure any quality system gaps are revealed and addressed
  • Important regulations that have direct impact on the process
  • Where incoming quality systems are prone to noncompliance
  • How an experienced third party consultant can be a valuable asset during the process

Whether you’re a VP, Director, Regulatory Affairs Manager, Quality Assurance Professional, Consultant, or anyone else involved in ensuring regulatory compliance is maintained, you'll come away with actionable takeaways you can use to make informed decisions before, during, and after absorbing a new quality system.

About the Presenter

The FDA Group's Larry Stevens, RAC

Presenter Larry Stevens, RAC, has held almost every field position within FDA during his 21-year career with the Agency. He has over 18 years of experience in the medical device industry, rising from an RA Manager to Vice President of RA/QA/Clinical for major class III device manufacturers.
 
He specializes in planning, creating, and auditing quality systems as well as creating clinical plans, including protocol development, case report form development, and implementing and managing clinical trials. He also assists in design control to meet FDA requirements. Larry is a professional speaker who regularly trains on all aspects of FDA requirements while offering practical, successful solutions to FDA problems.